These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4144409)

  • 21. Monoaminergic presynaptic axons and dendrites in rat locus coeruleus seen in reconstructions of serial sections.
    Groves PM; Wilson CJ
    J Comp Neurol; 1980 Oct; 193(4):853-62. PubMed ID: 7430441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The inhibition of (3H) biogenic amine accumulation into rat brain tissue slices by various tryptamine derivatives.
    Heikkila RE; Cohen G
    Res Commun Chem Pathol Pharmacol; 1974 Mar; 7(3):539-47. PubMed ID: 4824828
    [No Abstract]   [Full Text] [Related]  

  • 23. Specificity of 6-hydroxydopamine induced degeneration of central monoamine neurones: an electron and fluorescence microscopic study with special reference to intracerebral injection on the nigro-striatal dopamine system.
    Hökfelt T; Ungerstedt U
    Brain Res; 1973 Oct; 60(2):269-97. PubMed ID: 4763613
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of central alterations of serotoninergic neurons upon the sleep-waking cycle.
    Jouvet M; Pujol JF
    Adv Biochem Psychopharmacol; 1974; 11(0):199-209. PubMed ID: 4367646
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of chronic treatment with l-sulpiride and haloperidol on central monoaminergic mechanisms.
    Fuxe K; Ogren SO; Hall H; Agnati LF; Andersson K; Köhler C; Schwarcz R
    Adv Biochem Psychopharmacol; 1980; 24():193-206. PubMed ID: 6967676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultrastructural aspects of neurotransmitter storage in adrenergic nerves.
    Jaim-Etcheverry G; Zieher LM
    Adv Cytopharmacol; 1971 May; 1():343-61. PubMed ID: 4127777
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of tricyclic antidepessants on attack elicited by hypothalamic stimulation: relation to brain biogenic amines.
    Dubinsky B; Karpowicz JK; Goldberg ME
    J Pharmacol Exp Ther; 1973 Dec; 187(3):550-7. PubMed ID: 4272322
    [No Abstract]   [Full Text] [Related]  

  • 28. [Localization of biogenic monoamines in the dura mater of the rat brain].
    Motavkin PA; Karedina VS; Kozhevnikova TA
    Arkh Anat Gistol Embriol; 1985 May; 88(5):11-6. PubMed ID: 2862857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum toxin type a (150 kDa) decreases exaggerated neurotransmitter release from trigeminal ganglion neurons and relieves neuropathy behaviors induced by infraorbital nerve constriction.
    Kitamura Y; Matsuka Y; Spigelman I; Ishihara Y; Yamamoto Y; Sonoyama W; Kamioka H; Yamashiro T; Kuboki T; Oguma K
    Neuroscience; 2009 Apr; 159(4):1422-9. PubMed ID: 19409226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of degeneration of adrenergic neurons after prolonged treatment with debrisoquin.
    Haeusler G; Lorez HP; Bartholini G; Kettler R; Tranzer JP
    J Pharmacol Exp Ther; 1974 Jun; 189(3):646-58. PubMed ID: 4152315
    [No Abstract]   [Full Text] [Related]  

  • 31. [Changes in and modulation of receptor activity in hepatic encephalopathy].
    Kienzl E; Riederer P; Brücke T; Kleinberger G; Jellinger K
    Infusionsther Klin Ernahr; 1985 Feb; 12(1):32, 37-45. PubMed ID: 2859245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine supersensitivity in the hypothalamus?
    Reid JL
    Adv Neurol; 1975; 9():73-80. PubMed ID: 167569
    [No Abstract]   [Full Text] [Related]  

  • 33. The mysterious trace amines: protean neuromodulators of synaptic transmission in mammalian brain.
    Burchett SA; Hicks TP
    Prog Neurobiol; 2006 Aug; 79(5-6):223-46. PubMed ID: 16962229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Neurohumoral transmitter mechanisms at the cellular level].
    Pletscher A
    Schweiz Arch Neurol Neurochir Psychiatr; 1979; 125(2):193-203. PubMed ID: 45339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Enzymatic methods for the identification of a transmitter substance in a specific brain nucleus (author's transl)].
    Kataoka K; Sorimachi M
    Tanpakushitsu Kakusan Koso; 1974 Jul; 19(7):537-49. PubMed ID: 4154482
    [No Abstract]   [Full Text] [Related]  

  • 36. The inhibition of 3 H-biogenic amine uptake by 5,6-dihydroxytryptamine: a comparison with the effects of 6-hydroxydopamine.
    Heikkila RE; Cohen G
    Eur J Pharmacol; 1973 Jan; 21(1):66-9. PubMed ID: 4709207
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of the neuronal cell body in neurotoxic injury.
    Sterman AB
    Neurobehav Toxicol Teratol; 1982; 4(5):493-4. PubMed ID: 6294540
    [No Abstract]   [Full Text] [Related]  

  • 38. Degeneration of noradrenergic nerve terminals in submucous ganglia of the rat duodenum following treatment with 6-hydroxydopamine.
    Wong WC; Helme RD; Smith GC
    Experientia; 1974 Mar; 30(3):282-4. PubMed ID: 4824608
    [No Abstract]   [Full Text] [Related]  

  • 39. Monoamine metabolites: their relationship and lack of relationship to monoaminergic neuronal activity.
    Commissiong JW
    Biochem Pharmacol; 1985 Apr; 34(8):1127-31. PubMed ID: 2581578
    [No Abstract]   [Full Text] [Related]  

  • 40. Chemical degeneration of indolamine axons in rat brain by 5,6-dihydroxytryptamine. An ultrastructural study.
    Baumgarten HG; Björklund A; Holstein AF; Nobin A
    Z Zellforsch Mikrosk Anat; 1972; 129(2):256-71. PubMed ID: 5042772
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.